Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants

Stock Track

05/05

Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.

The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.

Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1156798443"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1156798443\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1156798443?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-05 21:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1156798443","market":"nz","top_or_hot":-1,"title":"Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants","media":"Stock Track","content":"<p>Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.</p><p>The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.</p><p>Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Twist Bioscience Soars 5.87% Intraday on Analyst Upgrades and New Hire Equity Grants\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-05 21:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.</p><p>The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.</p><p>Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1156798443","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1156798443","pubTimestamp":1777988697,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.The surge comes after multiple investment firms upgraded their...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"个股追踪|Twist Bioscience因分析师升级和新员工股权授予盘中飙升5.87%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"Twist Bioscience Corporation's stock soared 5.87% during intraday trading on Tuesday, following a series of positive analyst actions.The surge comes after multiple investment firms upgraded their ratings and raised price targets for the company. Leerink Partners upgraded Twist Bioscience to Outperform from Market Perform and increased its price target to $70 from $55. Similarly, Barclays raised its target price to $65 from $55, and TD Cowen lifted its target to $68 from $58.Additionally, the company announced it has granted 115,279 inducement equity awards to 53 newly hired employees under its Amended and Restated Inducement Equity Incentive Plan. This move signals ongoing expansion and investment in human capital, which may have further bolstered investor confidence.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}